Investor Centre logo
ICU
Financial Services

Investor Centre

Short interest
0.00%
0.00 pp 30d
as of 10 Nov 2017
Reported shorts
1
Shares on issue
169.630M

Investor Centre (ICU) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$83.6K (source: ASX (Markit))vs $148.8K (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
NPAT
−$724.4K (source: ASX (Markit))vs −$1.5M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
EPS (basic)
n/avs −$0.004 (source: Derived: trailing 12 months at year end) (FY25)
Rev YoY
−43.8%FY
EPS YoY
n/aFY
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of Preliminary Final Report, 2 Sep 2026

Investor Centre Limited reported revenue of $83,590 for the year ended 30 June 2026, down 46.4% from $155,850 in the prior year, and a net loss after tax of $724,416, which was a 36.8% improvement on the prior year's loss of $1,145,343. No dividends were paid, proposed, or declared during the period. The company faced significant financial and operational challenges, including the liquidation of a major funder and the cancellation of its subsidiary's AFSL, and is in discussions with a new debt holder regarding restructuring and recapitalisation.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
n/a
Operating margin
n/a
Net margin
−866.6%
FCF margin
n/a
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (listed unit is not one ordinary share)
P/E
n/a (listed unit is not one ordinary share)
P/B
n/a (listed unit is not one ordinary share)

Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

ICU income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$83.6K (source: ASX (Markit))$148.8K (source: ASX (Markit))−$992.6K$15.8K
EBITDAn/a−$1.0M (source: Derived: trailing 12 months at year end)−$1.7M−$1.3M
EBITn/a−$1.0M (source: Derived: trailing 12 months at year end)−$1.7M−$1.3M
Interest expensen/a$269.8K (source: Derived: trailing 12 months at year end)$194.4K$78.4K
Pretax incomen/a−$1.3M (source: Derived: trailing 12 months at year end)−$1.9M−$1.4M
Taxn/a$0 (source: Derived: trailing 12 months at year end)$0$0
NPAT−$724.4K (source: ASX (Markit))−$1.5M (source: ASX (Markit))−$1.9M−$1.4M
Net interest incomen/a−$269.8K (source: Derived: trailing 12 months at year end)−$194.3K−$77.8K
EPS basicn/a−$0.004 (source: Derived: trailing 12 months at year end)−$0.006−$0.007
EPS dilutedn/a−$0.004 (source: Derived: trailing 12 months at year end)−$0.006−$0.007
Sharesn/an/a304.5M286.6M
  • ASX (Markit)
  • Derived: trailing 12 months at year end